Filing Details

Accession Number:
0001555280-21-000100
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-16 17:16:16
Reporting Period:
2021-02-11
Accepted Time:
2021-02-16 17:16:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1555280 Zoetis Inc. ZTS Pharmaceutical Preparations (2834) 460696167
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1798683 Edward Robert Kelly C/O Zoetis Inc.
10 Sylvan Way
Parsippany NJ 07054
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-11 821 $26.00 10,029 No 4 M Direct
Common Stock Acquisiton 2021-02-11 729 $30.89 10,758 No 4 M Direct
Common Stock Disposition 2021-02-11 2,054 $161.15 8,704 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2021-02-11 821 $0.00 821 $0.00
Common Stock Stock Option Disposition 2021-02-11 729 $0.00 729 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
51,513 No 4 M Direct
50,784 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2020.
  2. The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.
  3. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.
  4. 821 options granted January 31, 2013 at an exercise price of $26.00 per option.
  5. Each option vests on the third anniversary of the date of grant.
  6. Each option expires on the tenth anniversary of the date of grant.
  7. 9,022 options granted January 31, 2013 at an exercise price of $26.00 per option; 8,739 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option.
  8. 729 options granted March 4, 2014 at an exercise price of $30.89 per option.
  9. 9,022 options granted January 31, 2013 at an exercise price of $26.00 per option; 8,010 options granted March 4, 2014 at an exercise price of $30.89 per option; 4,141 options granted February 27, 2015 at an exercise price of $46.09 per option; 5,212 options granted February 19, 2016 at an exercise price of $41.83 per option; 4,428 options granted February 14, 2017 at an exercise price of $55.02 per option; 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option; 3,443 options granted February 12, 2019 at an exercise price of $87.51 per option; 6,633 options granted February 11, 2020 at an exercise price of $144.03 per option; and 6,610 options granted February 10, 2021 at an exercise price of $160.62 per option.